ARTICLE | Company News
PowderJect, Glaxo Wellcome deal
March 27, 2000 8:00 AM UTC
GLX will buy an additional DNA vaccine license using PJP's needle-free drug delivery technology in an undisclosed therapeutic area under the companies' 1998 alliance (see BioCentury Extra, March 4, 19...